On April 28, 2024, a delegation from Shaya County, Aksu Region, including Ning Xia , member of the Standing Committee of the County Party Committee and Vice Governor of Shaya County, Xu Yu, Deputy Director of the County People's Congress and Secretary of the Party Group of the Development and Reform Commission, Wenhai He , Secretary of the Party Group of the County Bureau of Industry and Commerce, and Yupeng Huang, Manager of the County Investment Promotion Company and his entourage of four, conducted in-depth exchanges and discussions with Dayou Unicorn on the opportunities and challenges for the development of the hollow capsule industry of plant-based materials.

On March 14, 2024, our Gansu plant hollow capsule construction project, as a key development project in Liangzhou District, Wuwei City, was honored to participate in the Liangzhou District 2024 First Quarter Investment Projects Concentration Groundbreaking Ceremony.

Fei Hong, vice president of the China Academy of Industrial Development, also said that in the "14th Five-Year Plan" for the development of the pharmaceutical industry, mentioned that biopharmaceuticals, pharmaceutical auxiliary materials, etc., is related to the people's livelihood, economic development and national security of the strategic industries, is an important foundation for the construction of a healthy China. In the '14th Five-Year' period, the new development stage of the pharmaceutical auxiliary materials and other fields put forward higher quality requirements, requiring the acceleration of the production of high value-added products to enhance international competitiveness.

Biomedical industry is a strategic emerging industry, one of the four leading pillar industries in Jinan City, which implements the development strategy of "Strong City with Industry", and is an important support to meet the people's demand for a healthy life, protect the health and safety of the nation, and build a strong public health system. 2023, there were 598 biomedical enterprises above the scale of Jinan City, and their operating revenue amounted to 222.96 billion yuan, with a year-on-year growth of 9.3%. In 2023, there will be 598 biopharmaceutical enterprises above scale in Jinan City, realizing an operating income of 222.96 billion yuan, an increase of 9.3% year-on-year; and the scale of chemical and biopharmaceutical industries will rank first in the province.

In the vibrant Shanghai headquarters, DYTZ recently successfully held the 2024 Annual Staff Mobilization Meeting. The event not only gathered all the staff from Shanghai headquarters, but also welcomed important key members from Hebei Pilot Base, Northeast Project Company and Northwest Project Company to celebrate this important moment of the year, demonstrating the spirit of unity and common progress.

Good news came from Unicorn that the company has recently obtained five national patents and relevant patent certificates issued by the China National Intellectual Property Administration.

Recently, the People's Government of Jinling Town, Zhaoyuan City successfully signed a contract with Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. to produce 40 billion plant capsules annually. Wang Xiaogang, a member of the Standing Committee and Vice Mayor of Zhaoyuan City, Yang Guang, Vice Chairman of the Zhaoyuan Municipal Political Consultative Conference and Director of the Commerce Bureau, Sheng Haixiang, Secretary of the Jinling Town Party Committee, Ren Zhumei, Mayor of Jinling Town Government, Song Yunqiang, General Manager of Dayou Shuoneng Industrial Co., Ltd., and Liu Naiyu, General Manager of Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. attended the signing ceremony.

On October 18th, the People's Government of Liangzhou District in Wuwei City successfully signed a contract with Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. for the 40 billion plant capsule project. Cui Zhenhua, Deputy Secretary of the Liangzhou District Committee and District Government Mayor of Wuwei City, attended the signing ceremony and delivered a speech, expressing full support for providing services around the project settlement. Liu Naiyu, Chairman of Dayou Unicorn, signed a cooperation agreement with the Liangzhou District People's Government of Wuwei City as the signing representative.

Precision medicine is a cutting-edge field in global biopharmaceutical technology, representing the development trend of future life sciences. Promoting the transformation of technological innovation achievements in this field is of great significance for China to achieve the strategy of becoming a technology powerhouse and a healthy China. As one of the key activities of the "2023 Shanghai Biomedical Industry Week", today (October 17), the "Gathering Moments to Seek Far Precision Jiasu" 2023 Jiading Precision Medicine Industry Development Conference and 2023 Precision Medicine Industrialization (Shanghai) Forum were successfully held in Jiading, Shanghai.